510(k) K863488— ENZYGNOST ANTI-CMV IGG TEST

Substantially Equivalent

Behring Diagnostics, Inc.

Clearance details

Applicant: Behring Diagnostics, Inc.
Product code: Code GQI
Advisory panel: Microbiology
Date received: 1986-09-09
Decision date: 1987-07-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: La Jolla, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.